IFNA1 and myeloproliferative disorder: Indeed, ATO strongly potentiates the efficiency of IFN in a mouse model of Jak2V617F myeloproliferative neoplasm, allowing leukemia-initiating cell clearance (Dagher et al., 2021; Fig. 2).